申请人:Berlex Laboratories, Inc.
公开号:US04415587A1
公开(公告)日:1983-11-15
Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.
本文描述了一种1,2-二取代咪唑(in)的小说化合物。这些化合物通常是通过将卤代酰苯胺与过量的2-取代咪唑(in)反应而产生的。这些化合物是抗心律失常药物。